Alligator contracts BioInvent for process development and cGMP manufacturing of the immuno-oncology drug candidate ADC-1015Alligator Bioscience AB is a privately held Swedish biotech company …Read more »
- 28 September, 2016 - 30 September, 2016World Bispecific Antibody Summit, Boston, US
Alligator Bioscience has a broad project portfolio with several antibody-based pharmaceuticals in immuno-oncology. Several of these R&D projects are operated in-house. The company's most advanced project, ADC-1013, is in clinical Phase I and is being developed together with partner Janssen Biotech.